Literature DB >> 25844550

Ovarian sex cord-stromal tumors in patients with probable or confirmed germline DICER1 mutations.

E Ebo Oost1, Adrian Charles, Catherine S Choong, Yee C Leung, Stuart Salfinger, Hein Sonnendecker, Jason Tan, Sharron Townshend, Leora Witkowski, William D Foulkes, Colin J R Stewart.   

Abstract

The DICER1 gene encodes an endoribonuclease involved in the production of mature microRNAs which regulates gene expression through several mechanisms. Recent studies have demonstrated somatic mutations in DICER1 in approximately 60% of ovarian Sertoli-Leydig cell tumors. Furthermore, patients with germline mutations in DICER1 are predisposed to developing a range of rare neoplasms including ovarian sex cord-stromal tumors most of which have been classified as Sertoli-Leydig cell tumor. However, the histologic features of these tumors have not been reported in detail. We describe the morphologic and immunophenotypic findings of 4 sex cord-stromal tumors arising in patients with proven or likely germline DICER1 mutations including 3 individuals from 1 family. Three tumors showed similar appearances characterized by marked architectural and cytologic heterogeneity including sertoliform, juvenile granulosa cell tumor-like, and unclassifiable elements. The remaining case mainly showed heterologous mucinous epithelial and neuroendocrine differentiation with only a minor intermediate-grade Sertoli cell component. This tumor and one of the 3 former cases arose in related patients with identical germline DICER1 mutations indicating that additional factors influence tumor morphology. All tumors were positive for steroidogenic factor-1 and FOXL2 on immunohistochemical analysis, whereas there was more variable expression of inhibin, calretinin, CD56, CD99, and hormone receptors. The present small series suggests that some ovarian Sertoli-Leydig cell tumor associated with germline DICER1 mutations may show distinctive histologic features in particular admixed Sertoli cell and juvenile granulosa cell tumor-like features. Larger studies are required to establish whether heterologous elements are also a more common feature of these tumors.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25844550     DOI: 10.1097/PGP.0000000000000150

Source DB:  PubMed          Journal:  Int J Gynecol Pathol        ISSN: 0277-1691            Impact factor:   2.762


  6 in total

1.  DICER1-related Sertoli-Leydig cell tumor and gynandroblastoma: Clinical and genetic findings from the International Ovarian and Testicular Stromal Tumor Registry.

Authors:  Kris Ann P Schultz; Anne K Harris; Michael Finch; Louis P Dehner; Jubilee B Brown; David M Gershenson; Robert H Young; Amanda Field; Weiying Yu; Joyce Turner; Nicholas G Cost; Dominik T Schneider; Douglas R Stewart; A Lindsay Frazier; Yoav Messinger; D Ashley Hill
Journal:  Gynecol Oncol       Date:  2017-10-14       Impact factor: 5.482

Review 2.  The co-occurrence of an ovarian Sertoli-Leydig cell tumor with a thyroid carcinoma is highly suggestive of a DICER1 syndrome.

Authors:  Emeline Durieux; Françoise Descotes; Claire Mauduit; Myriam Decaussin; Serge Guyetant; Mojgan Devouassoux-Shisheboran
Journal:  Virchows Arch       Date:  2016-03-16       Impact factor: 4.064

3.  DICER1 mutation and tumors associated with a familial tumor predisposition syndrome: practical considerations.

Authors:  Eduardo J Bardón-Cancho; Ana Haro-Díaz; Francisco J Alonso-García-de la Rosa; Jorge Huerta-Aragonés; Marina García-Morín; Felipe González-Martínez; Carmen Garrido-Colino
Journal:  Fam Cancer       Date:  2017-04       Impact factor: 2.375

Review 4.  Spectrum of DICER1 Germline Pathogenic Variants in Ovarian Sertoli-Leydig Cell Tumor.

Authors:  Elisa De Paolis; Rosa Maria Paragliola; Paola Concolino
Journal:  J Clin Med       Date:  2021-04-23       Impact factor: 4.241

5.  A survey of DICER1 hotspot mutations in ovarian and testicular sex cord-stromal tumors.

Authors:  Niamh Conlon; Anne M Schultheis; Salvatore Piscuoglio; Annacarolina Silva; Esther Guerra; Carmen Tornos; Victor E Reuter; Robert A Soslow; Robert H Young; Esther Oliva; Britta Weigelt
Journal:  Mod Pathol       Date:  2015-10-02       Impact factor: 7.842

Review 6.  DICER1 Syndrome: DICER1 Mutations in Rare Cancers.

Authors:  Jake C Robertson; Cheryl L Jorcyk; Julia Thom Oxford
Journal:  Cancers (Basel)       Date:  2018-05-15       Impact factor: 6.639

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.